• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

银屑病与特应性皮炎患者血液学参数及免疫炎症标志物的对比研究。

Comparative Study of Hematological Parameters and Biomarkers of Immunity and Inflammation in Patients with Psoriasis and Atopic Dermatitis.

机构信息

Clinic for Dermatovenerology, Clinical Center of Montenegro, 81000 Podgorica, Montenegro.

Faculty of Medicine, University of Montenegro, 81000 Podgorica, Montenegro.

出版信息

Medicina (Kaunas). 2023 Sep 8;59(9):1622. doi: 10.3390/medicina59091622.

DOI:10.3390/medicina59091622
PMID:37763741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10535769/
Abstract

: There are no studies regarding comparative analysis of hematological parameters in patients with psoriasis (PsO) and atopic dermatitis (AD), whereas studies examining serum biomarkers of immunity and inflammation in these entities are scarce and contradictory. We aimed to compare such parameters in patients with PsO and AD. : Patients with PsO ( = 40) and AD ( = 40) were consecutively included in this cross-sectional study. Hematological parameters and biomarkers of immunity and inflammation (interferon-gamma (IFN-γ), interleukine (IL)-22 and C-reactive protein (CRP)) were determined. : While the mean corpuscular volume (MCV) was higher in the PsO group vs. the AD group ( < 0.05), there was no difference in the other examined parameters between groups. A higher neutrophil-to-lymphocyte ratio (NLR) was found in patients with AD > 50 years vs. patients with PsO of similar age ( < 0.05). Higher IL-22 levels were found in patients with AD < 50 years vs. patients with PsO of similar age ( < 0.05). Lower IL-22 levels were found in patients with AD > 50 years vs. patients with AD < 50 years ( < 0.05). Patients with PsO and with comorbidities had lower platelets (PLT), plateletcrit (PCT) and platelet-to-lymphocyte ratio (PLR), whereas lymphocytes, red cell distribution width-to-PLT ratio (RPR) and mean platelet volume/PLT ratio (MPR) were higher vs. PsO patients without comorbidities. Patients with AD and with comorbidities had lower PCT and PLR, whereas RPR was higher vs. AD patients without comorbidities. : A higher pro-inflammatory state (i.e., higher NLR and IL-22) was found in AD vs. PsO in age-specific groups. A higher pro-inflammatory state (i.e., as reflected by platelet indexes) was found in both diseases with comorbidities.

摘要

: 目前尚无关于银屑病(PsO)和特应性皮炎(AD)患者血液学参数比较分析的研究,而关于这些疾病的免疫和炎症血清生物标志物的研究则很少且存在矛盾。我们旨在比较 PsO 和 AD 患者的这些参数。 : 本横断面研究连续纳入了 40 例 PsO 患者和 40 例 AD 患者。测定了血液学参数以及免疫和炎症的生物标志物(干扰素-γ(IFN-γ)、白细胞介素(IL)-22 和 C 反应蛋白(CRP))。 : 与 AD 组相比,PsO 组的平均红细胞体积(MCV)更高(<0.05),但两组间其他检查参数无差异。50 岁以上 AD 患者的中性粒细胞与淋巴细胞比值(NLR)高于同龄 PsO 患者(<0.05)。50 岁以下 AD 患者的 IL-22 水平高于同龄 PsO 患者(<0.05)。50 岁以上 AD 患者的 IL-22 水平低于 50 岁以下 AD 患者(<0.05)。合并症的 PsO 患者的血小板(PLT)、血小板压积(PCT)和血小板与淋巴细胞比值(PLR)较低,而淋巴细胞、红细胞分布宽度与 PLT 比值(RPR)和平均血小板体积/PLT 比值(MPR)则较高。合并症的 AD 患者的 PCT 和 PLR 较低,而 RPR 则较高。 : 在特定年龄组中,AD 患者的促炎状态(即更高的 NLR 和 IL-22)高于 PsO 患者。两种疾病合并症患者的促炎状态(如血小板指标所示)更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d7/10535769/440d2eb2d03f/medicina-59-01622-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d7/10535769/a93e55cd328d/medicina-59-01622-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d7/10535769/440d2eb2d03f/medicina-59-01622-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d7/10535769/a93e55cd328d/medicina-59-01622-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/79d7/10535769/440d2eb2d03f/medicina-59-01622-g002.jpg

相似文献

1
Comparative Study of Hematological Parameters and Biomarkers of Immunity and Inflammation in Patients with Psoriasis and Atopic Dermatitis.银屑病与特应性皮炎患者血液学参数及免疫炎症标志物的对比研究。
Medicina (Kaunas). 2023 Sep 8;59(9):1622. doi: 10.3390/medicina59091622.
2
Comparative Analysis of Redox Homeostasis Biomarkers in Patients with Psoriasis and Atopic Dermatitis.银屑病和特应性皮炎患者氧化还原稳态生物标志物的比较分析
Antioxidants (Basel). 2023 Oct 18;12(10):1875. doi: 10.3390/antiox12101875.
3
Prevalence of comorbidities in atopic dermatitis and psoriasis in the French population.法国人群中特应性皮炎和银屑病的共病患病率。
Ann Dermatol Venereol. 2021 Mar;148(1):28-33. doi: 10.1016/j.annder.2020.02.015. Epub 2021 Jan 23.
4
A comparative study of childhood psoriasis and atopic dermatitis and greater understanding of the overlapping condition, psoriasis-dermatitis.儿童银屑病与特应性皮炎的对比研究,以及对重叠病症(银屑病-皮炎)的更深入了解。
Australas J Dermatol. 2012 May;53(2):98-105. doi: 10.1111/j.1440-0960.2012.00878.x.
5
The İmportance of hematological parameters in the prognosis of patients with severe COVID-19, A single-center retrospective study.严重 COVID-19 患者预后的血液学参数的重要性:一项单中心回顾性研究。
Niger J Clin Pract. 2023 Sep;26(9):1297-1302. doi: 10.4103/njcp.njcp_22_23.
6
The Relationship of Hematological Parameters and C-reactive Protein (CRP) With Disease Presence, Severity, and Response to Systemic Therapy in Patients With Psoriasis.银屑病患者血液学参数及C反应蛋白(CRP)与疾病存在、严重程度及全身治疗反应的关系
Cureus. 2023 Aug 20;15(8):e43790. doi: 10.7759/cureus.43790. eCollection 2023 Aug.
7
Hematological Markers in Children and Adults with Atopic Dermatitis: A Retrospective Cohort Study.儿童和成人特应性皮炎的血液学标志物:一项回顾性队列研究。
Dermatology. 2024;240(4):597-605. doi: 10.1159/000539365. Epub 2024 May 28.
8
Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: Response to therapy with biologics.中性粒细胞-淋巴细胞比值、血小板-淋巴细胞比值和平均血小板体积在日本银屑病和银屑病关节炎患者中的变化:生物制剂治疗的反应。
J Dermatol. 2017 Oct;44(10):1112-1121. doi: 10.1111/1346-8138.13875. Epub 2017 May 11.
9
Assessment of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Atopic Dermatitis Patients.特应性皮炎患者中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值的评估
Med Sci Monit. 2017 Mar 17;23:1340-1346. doi: 10.12659/msm.900212.
10
Elevated Platelet Parameter in First-Episode Schizophrenia Patients: A Cross-Sectional Study.首发精神分裂症患者血小板参数升高:一项横断面研究。
J Interferon Cytokine Res. 2020 Nov;40(11):524-529. doi: 10.1089/jir.2020.0117. Epub 2020 Oct 29.

引用本文的文献

1
Cardiovascular risk in patients with a relationship with oxidative stress and dyslipidemia.与氧化应激和血脂异常相关的患者的心血管风险。
J Med Biochem. 2025 Jun 13;44(3):614-621. doi: 10.5937/jomb0-52038.
2
Early Cerebral Microvasculature Impairment and Increased Body Mass Index in Patients with Psoriasis.银屑病患者早期脑微血管损伤与体重指数增加
Biomedicines. 2024 Jul 23;12(8):1627. doi: 10.3390/biomedicines12081627.
3
Impact of Blood-Count-Derived Inflammatory Markers in Psoriatic Disease Progression.血常规衍生的炎症标志物在银屑病疾病进展中的影响

本文引用的文献

1
Oxidative stress and metabolic biomarkers in patients with Psoriasis.银屑病患者的氧化应激和代谢生物标志物
J Med Biochem. 2024 Jan 25;43(1):97-105. doi: 10.5937/jomb0-45076.
2
The role of Janus kinase signaling in the pathology of atopic dermatitis.Janus激酶信号传导在特应性皮炎病理学中的作用。
J Allergy Clin Immunol. 2023 Dec;152(6):1394-1404. doi: 10.1016/j.jaci.2023.07.010. Epub 2023 Aug 1.
3
Impact of Pretreatment Systemic Inflammatory Markers on Treatment Persistence with Biologics and Conventional Systemic Therapy: A Retrospective Study of Patients with Psoriasis Vulgaris and Psoriatic Arthritis.
Life (Basel). 2024 Jan 12;14(1):114. doi: 10.3390/life14010114.
4
Comparative Analysis of Redox Homeostasis Biomarkers in Patients with Psoriasis and Atopic Dermatitis.银屑病和特应性皮炎患者氧化还原稳态生物标志物的比较分析
Antioxidants (Basel). 2023 Oct 18;12(10):1875. doi: 10.3390/antiox12101875.
治疗前全身炎症标志物对生物制剂和传统全身治疗持续治疗的影响:一项寻常型银屑病和银屑病关节炎患者的回顾性研究
J Clin Med. 2023 Apr 21;12(8):3046. doi: 10.3390/jcm12083046.
4
Do Platelet Count and mean Platelet Volume have a Predictive Role as a Marker in Children with Atopic Dermatitis?血小板计数和平均血小板体积作为特应性皮炎患儿的标志物是否具有预测作用?
Indian J Dermatol. 2022 Nov-Dec;67(6):688-692. doi: 10.4103/ijd.ijd_689_22.
5
Therapeutic effects of mesenchymal stem cells and their derivatives in common skin inflammatory diseases: Atopic dermatitis and psoriasis.间充质干细胞及其衍生物在常见皮肤炎症性疾病中的治疗作用:特应性皮炎和银屑病。
Front Immunol. 2023 Feb 20;14:1092668. doi: 10.3389/fimmu.2023.1092668. eCollection 2023.
6
Exploring the association and causal effect between white blood cells and psoriasis using large-scale population data.利用大规模人群数据探索白细胞与银屑病之间的关联和因果关系。
Front Immunol. 2023 Feb 14;14:1043380. doi: 10.3389/fimmu.2023.1043380. eCollection 2023.
7
New frontiers in personalized medicine in psoriasis.银屑病个性化医疗的新前沿。
Expert Opin Biol Ther. 2022 Dec;22(12):1431-1433. doi: 10.1080/14712598.2022.2113872. Epub 2022 Aug 16.
8
Immunological differences between atopic dermatitis, psoriasis, and their combination in adult patients.成人特应性皮炎、银屑病及其合并症患者的免疫学差异。
Allergol Immunopathol (Madr). 2022 Jul 1;50(4):143-146. doi: 10.15586/aei.v50i4.557. eCollection 2022.
9
Novel leukocyte and thrombocyte indexes in patients with prediabetes and type 2 diabetes mellitus.新型白细胞和血小板指标在糖尿病前期和 2 型糖尿病患者中的变化。
Eur Rev Med Pharmacol Sci. 2022 Apr;26(8):2775-2781. doi: 10.26355/eurrev_202204_28607.
10
The association between platelet indices and presence and severity of psoriasis: a systematic review and meta-analysis.血小板指标与银屑病的存在及严重程度之间的关联:一项系统综述和荟萃分析。
Clin Exp Med. 2023 Jun;23(2):333-346. doi: 10.1007/s10238-022-00820-5. Epub 2022 Apr 4.